Outcome of Board Meeting dated May 15, 2026
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 1.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jupiter Life Line Hospitals reported FY2026 consolidated revenue of Rs 14,998 million (up 15.2% YoY) and PAT of Rs 1,942 million (flat YoY at +0.2%). Standalone revenue grew 19.3% to Rs 12,768 million with PAT of Rs 1,563 million (+3.9% YoY). The Board declared an interim dividend of Rs 1 per share (10% on Rs 10 face value) with record date May 22, 2026. A stock split was approved — 1 equity share of Rs 10 will be subdivided into 5 shares of Rs 2 each. Dr. Ajay Thakker was elevated to Chairman & Whole Time Director. Joint statutory auditors issued an unmodified opinion on both standalone and consolidated results. An exceptional charge of Rs 48.87 million was recorded due to increased gratuity liability under new Indian labour codes. Consolidated borrowings rose significantly to Rs 5,009 million from Rs 3,217 million in the prior year.
Solid topline growth of ~15-19% with flat bottom-line due to higher finance costs and exceptional items. The stock split improves affordability for retail investors. Dividend provides near-term cash return. Rising debt levels warrant monitoring.